1. Home
  2. TKO vs MDGL Comparison

TKO vs MDGL Comparison

Compare TKO & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$205.40

Market Cap

14.5B

Sector

N/A

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$482.19

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKO
MDGL
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
12.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TKO
MDGL
Price
$205.40
$482.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
14
Target Price
$223.56
$597.54
AVG Volume (30 Days)
853.8K
312.8K
Earning Date
02-25-2026
02-25-2026
Dividend Yield
1.52%
N/A
EPS Growth
N/A
N/A
EPS
1.85
N/A
Revenue
$2,545,175,000.00
$740,640,000.00
Revenue This Year
$69.88
$435.62
Revenue Next Year
$29.58
$52.67
P/E Ratio
$110.47
N/A
Revenue Growth
N/A
864.21
52 Week Low
$133.07
$265.00
52 Week High
$218.11
$615.00

Technical Indicators

Market Signals
Indicator
TKO
MDGL
Relative Strength Index (RSI) 51.30 31.14
Support Level $196.91 $483.55
Resistance Level $213.02 $511.94
Average True Range (ATR) 5.61 23.79
MACD -0.78 -6.68
Stochastic Oscillator 52.30 12.67

Price Performance

Historical Comparison
TKO
MDGL

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events, sponsorship, and consumer products licensing agreements of UFC-branded products.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: